Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018099895) SOLID ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING TENOFOVIR AND EMTRICITABINE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/099895 International Application No.: PCT/EP2017/080621
Publication Date: 07.06.2018 International Filing Date: 28.11.2017
IPC:
A61K 9/20 (2006.01) ,A61K 31/675 (2006.01) ,A61K 31/13 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
66
Phosphorus compounds
675
having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
Applicants:
ARVEN ILAC SANAYI VE TICARET A.S. [TR/TR]; Balabandere Cad. Ilac Sanayi Yolu No: 14 Istinye, Sariyer 34460 Istanbul, TR
Inventors:
TÜRKYILMAZ, Ali; TR
YILDIRIM, Ediz; TR
DEMIR, Bülent; TR
MURATOGLU, Yesim; TR
NURIOGLU, Ayda; TR
BAS, Oguz; TR
Agent:
SEVINC, Erkan; TR
Priority Data:
2016/1744829.11.2016TR
Title (EN) SOLID ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING TENOFOVIR AND EMTRICITABINE
(FR) COMPOSITIONS PHARMACEUTIQUES ORALES SOLIDES COMPRENANT DU TÉNOFOVIR ET DE L'EMTRICITABINE
Abstract:
(EN) The present invention relates to pharmaceutical compositions comprising tenofovir or a pharmaceutically acceptable salt thereof and emtricitabine or a pharmaceutically acceptable salt thereof. The invention further discloses a process for preparing tablet formulations thereof.
(FR) La présente invention concerne des compositions pharmaceutiques comprenant du ténofovir ou un sel pharmaceutiquement acceptable de celui-ci, et de l'emtricitabine ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne en outre un procédé de préparation de formulations pour comprimé de celles-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)